Global Pneumococcal Vaccine Market Growth 2020-2025

  • ID:PD013816
  • July 2020
  • LPI (LP Information)
                          

The global Pneumococcal Vaccine market report presents a complete research-based study of the industry including details such as company shares, forecast data, in-depth analysis and an outlook of the market on a worldwide platform. The report further highlights the market drivers, restraints and the top manufacturers at the global and regional levels. For a thorough understanding, the report also offers market segmentation and regional analysis for the forecast period from 2020 to 2025.
 
According to this study, over the next five years the Pneumococcal Vaccine market will register a 1.1%% CAGR in terms of revenue, the global market size will reach $ 7204.8 million by 2025, from $ 6885.1 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pneumococcal Vaccine business, shared in Chapter 3.
 
This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Vaccine market by product type, application, key manufacturers and key regions and countries.
 
This study specially analyses the impact of Covid-19 outbreak on the Pneumococcal Vaccine, covering the supply chain analysis, impact assessment to the Pneumococcal Vaccine market size growth rate in several scenarios, and the measures to be undertaken by Pneumococcal Vaccine companies in response to the COVID-19 epidemic.
 
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

  • PPSV 23
  • PCV 7/13
  • PCV 10
 
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
  • Child
  • Adult
 
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
 
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
  • Pfizer
  • GSK
  • Sanofipasteur
  • CDIBP
  • MSD
  • ...
 
 
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
 
Research objectives
 
  • To study and analyze the global Pneumococcal Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
  • To understand the structure of Pneumococcal Vaccine market by identifying its various subsegments.
  • Focuses on the key global Pneumococcal Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Pneumococcal Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Pneumococcal Vaccine submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

 

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pneumococcal Vaccine Consumption 2015-2025

2.1.2 Pneumococcal Vaccine Consumption CAGR by Region

2.2 Pneumococcal Vaccine Segment by Type

2.2.1 PPSV 23

2.2.2 PCV 7/13

2.2.3 PCV 10

2.3 Pneumococcal Vaccine Consumption by Type

2.3.1 Global Pneumococcal Vaccine Consumption Market Share by Type (2015-2020)

2.3.2 Global Pneumococcal Vaccine Revenue and Market Share by Type (2015-2020)

2.3.3 Global Pneumococcal Vaccine Sale Price by Type (2015-2020)

2.4 Pneumococcal Vaccine Segment by Application

2.4.1 Child

2.4.2 Adult

2.5 Pneumococcal Vaccine Consumption by Application

2.5.1 Global Pneumococcal Vaccine Consumption Market Share by Type (2015-2020)

2.5.2 Global Pneumococcal Vaccine Value and Market Share by Type (2015-2020)

2.5.3 Global Pneumococcal Vaccine Sale Price by Type (2015-2020)

 

3 Global Pneumococcal Vaccine by Company

3.1 Global Pneumococcal Vaccine Sales Market Share by Company

3.1.1 Global Pneumococcal Vaccine Sales by Company (2018-2020)

3.1.2 Global Pneumococcal Vaccine Sales Market Share by Company (2018-2020)

3.2 Global Pneumococcal Vaccine Revenue Market Share by Company

3.2.1 Global Pneumococcal Vaccine Revenue by Company (2018-2020)

3.2.2 Global Pneumococcal Vaccine Revenue Market Share by Company (2018-2020)

3.3 Global Pneumococcal Vaccine Sale Price by Company

3.4 Global Pneumococcal Vaccine Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Pneumococcal Vaccine Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Pneumococcal Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

 

4 Pneumococcal Vaccine by Regions

4.1 Pneumococcal Vaccine by Regions

4.2 Americas Pneumococcal Vaccine Consumption Growth

4.3 APAC Pneumococcal Vaccine Consumption Growth

4.4 Europe Pneumococcal Vaccine Consumption Growth

4.5 Middle East & Africa Pneumococcal Vaccine Consumption Growth

 

5 Americas

5.1 Americas Pneumococcal Vaccine Consumption by Countries

5.1.1 Americas Pneumococcal Vaccine Consumption by Countries (2015-2020)

5.1.2 Americas Pneumococcal Vaccine Value by Countries (2015-2020)

5.2 Americas Pneumococcal Vaccine Consumption by Type

5.3 Americas Pneumococcal Vaccine Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

 

6 APAC

6.1 APAC Pneumococcal Vaccine Consumption by Regions

6.1.1 APAC Pneumococcal Vaccine Consumption by Regions (2015-2020)

6.1.2 APAC Pneumococcal Vaccine Value by Regions (2015-2020)

6.2 APAC Pneumococcal Vaccine Consumption by Type

6.3 APAC Pneumococcal Vaccine Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

 

7 Europe

7.1 Europe Pneumococcal Vaccine by Countries

7.1.1 Europe Pneumococcal Vaccine Consumption by Countries (2015-2020)

7.1.2 Europe Pneumococcal Vaccine Value by Countries (2015-2020)

7.2 Europe Pneumococcal Vaccine Consumption by Type

7.3 Europe Pneumococcal Vaccine Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

 

8 Middle East & Africa

8.1 Middle East & Africa Pneumococcal Vaccine by Countries

8.1.1 Middle East & Africa Pneumococcal Vaccine Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Pneumococcal Vaccine Value by Countries (2015-2020)

8.2 Middle East & Africa Pneumococcal Vaccine Consumption by Type

8.3 Middle East & Africa Pneumococcal Vaccine Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

 

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

 

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Pneumococcal Vaccine Distributors

10.3 Pneumococcal Vaccine Customer

 

11 Global Pneumococcal Vaccine Market Forecast

11.1 Global Pneumococcal Vaccine Consumption Forecast (2021-2025)

11.2 Global Pneumococcal Vaccine Forecast by Regions

11.2.1 Global Pneumococcal Vaccine Forecast by Regions (2021-2025)

11.2.2 Global Pneumococcal Vaccine Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Pneumococcal Vaccine Forecast by Type

11.8 Global Pneumococcal Vaccine Forecast by Application

 

12 Key Players Analysis

12.1 Pfizer

12.1.1 Company Information

12.1.2 Pneumococcal Vaccine Product Offered

12.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Pfizer Latest Developments

12.2 GSK

12.2.1 Company Information

12.2.2 Pneumococcal Vaccine Product Offered

12.2.3 GSK Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 GSK Latest Developments

12.3 Sanofipasteur

12.3.1 Company Information

12.3.2 Pneumococcal Vaccine Product Offered

12.3.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Sanofipasteur Latest Developments

12.4 CDIBP

12.4.1 Company Information

12.4.2 Pneumococcal Vaccine Product Offered

12.4.3 CDIBP Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 CDIBP Latest Developments

12.5 MSD

12.5.1 Company Information

12.5.2 Pneumococcal Vaccine Product Offered

12.5.3 MSD Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 MSD Latest Developments

...

 

13 Research Findings and Conclusion

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts  read more..


Global Caffeine Market Insights, Forecast to 2025

Caffeine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast  read more..


Global Rabies Vaccine Market Insights, Forecast to 2025

Rabies Vaccine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Insights, Forecast to 2025

Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and  read more..


Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also  read more..